-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Amneal Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2017 to Q2 2024.
- Amneal Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $5.99M, a 49.7% decline year-over-year.
- Amneal Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$170M, a 1058% decline year-over-year.
- Amneal Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$79.3M, a 70.7% increase from 2022.
- Amneal Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$271M, a 2156% decline from 2021.
- Amneal Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $13.2M, a 80.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)